DPAM
REGN icon

Degroof Petercam Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Degroof Petercam Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$8.06M Buy
8,370
+900
+12% +$856K 0.1% 153
2023
Q4 		$6.56M Buy
+7,470
New +$6.15M 0.09% 184

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Degroof Petercam Asset Management's REGN Position: Q1 2024 in Review

Degroof Petercam Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q1 2024, buying an estimated $856K and bringing the position to 8,370 shares worth $8.06M. The position accounts for 0.1% of the portfolio, ranked #153.

Degroof Petercam Asset Management first reported a position in REGN in Q4 2023 and has held it in 2 quarters since. 1,310 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Degroof Petercam Asset Management held 8,370 shares of Regeneron Pharmaceuticals worth $8.06M as of Q1 2024.
  • Degroof Petercam Asset Management bought 900 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $856K.
  • Regeneron Pharmaceuticals made up 0.1% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #153 holding.
  • Degroof Petercam Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • 1,310 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.